Number of the records: 1
Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery
SYS 0618471 LBL 01000a^^22220027750^450 005 20250430094941.0 014 $a 105000612958 $2 SCOPUS 014 $a 40112897 $2 PUBMED 014 $a 001457041100001 $2 WOS 017 $a 10.1016/j.jconrel.2025.113645 $2 DOI 100 $a 20250327d m y slo 03 ba 101 $a eng 102 $a NL 200 1-
$a Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery 215 $a 17 s. 300 $a Erratum SCOPUS: 105002138039, 463 -1
$1 001 cav_un_epca*0256939 $1 011 $a 0168-3659 $e 1873-4995 $1 200 1 $a Journal of Controlled Release $v Roč. 381, May 10 (2025) $1 210 $c Elsevier 610 $a Multidrug resistance 610 $a P-glycoprotein inhibition 610 $a Sensitization to chemotherapy 610 $a Intracellular ATP depletion 610 $a HPMA copolymer 610 $a PPO 610 $a Diblock copolymers 610 $a Drug delivery system 700 -1
$3 cav_un_auth*0384265 $a Kaňa $b Martin $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0102996 $a Braunová $b Alena $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0461473 $a Starenko $b Daniil $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $y RU $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0442427 $a Frejková $b Markéta $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $y CZ $4 070 $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0108310 $a Bouček $b Jan $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104733 $a Říhová $b Blanka $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104580 $a Kovář $b Marek $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0103021 $a Etrych $b Tomáš $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104774 $a Šírová $b Milada $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $z K $T Mikrobiologický ústav AV ČR, v. v. i. 856 $u https://www.sciencedirect.com/science/article/pii/S0168365925002652 $9 RIV
Number of the records: 1